scispace - formally typeset
G

Gianni Passalacqua

Researcher at University of Genoa

Publications -  82
Citations -  8377

Gianni Passalacqua is an academic researcher from University of Genoa. The author has contributed to research in topics: Asthma & Allergy. The author has an hindex of 36, co-authored 82 publications receiving 7435 citations.

Papers
More filters
Journal ArticleDOI

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Jean Bousquet, +95 more
- 01 Apr 2008 - 
TL;DR: The ARIA guidelines for the management of allergic rhinitis and asthma are similar in both the 1999 ARIA workshop report and the 2008 Update as discussed by the authors, but the GRADE approach is not yet available.
Journal ArticleDOI

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan Brozek, +59 more
TL;DR: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR, addressing the relative merits of using oral H1‐antihistamines, intranasal H1-antihistsamines, IntranasAL corticosteroids, and leukotriene receptor antagonists either alone or in combination.
Journal ArticleDOI

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.

TL;DR: Investigation of the efficacy of SLIT with house dust mite (HDM) extracts in allergic patients suffering from AR and AA through an updated reassessment of randomized controlled trials suggests that more data are needed, derived from large‐population‐based high quality studies, and corroborated by objective outcomes.
Journal ArticleDOI

Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper

TL;DR: Characterization of the phenotype, mechanisms and management of NAR represents one of the major unmet needs in allergic and nonallergic diseases and its phenotypes need to be evaluated using appropriate methods to better understand its pathophysiology, diagnosis and management.
Journal ArticleDOI

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real‐life: clinical efficacy and more

TL;DR: In a randomized open, controlled, two parallel group study in a real‐life setting, magnitude of the clinical efficacy, effect on the bronchial hyperreactivity adherence to treatment, preventive effect of sublingual immunotherapy were clarified.